. He can be reached at nsaraceno@mjhlifesciences.com.

Videos

In the third part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & distribution services, breaks down the strategies should organizations prioritize to ensure compliance of the Aug. 27 DSCSA enforcement date.

Balancing Compliance and Supply Chain Continuity

Articles

Pharma Pulse 8/1/25: What Clinical Ops Teams Must Know About Biomarkers in Trials; What is the Timeline for True AI Implementation for Digital Twins?

In the fourth part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Nate Chenenko, principal with Ducker Carlisle, shares best practices for reducing greenhouse gas emissions across distribution channels without disrupting supply chain efficiency.

Emission-Reduction Strategies That Save Money and Preserve Performance

Is the industry ready for the Aug. 1 deadline of when these levies go into effect?

As Trump Pharma Tariff Deadline Looms, Here's How the Sector Got Here

In the second part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & distribution services, discusses the advanced technology and data-driven solutions that are proving most effective in enhancing real-time visibility and operational efficiency.

Using Data Loggers and Cold Chain Tech to Power Precision Pharma Delivery

Pharma Pulse 7/31/25: Where Has AI Already Been Successfully Implemented; How Biomarkers Are Transforming Neurology and Oncology Trials

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Nate Chenenko, principal with Ducker Carlisle details how manufacturers can overcome the data gaps from suppliers and third parties when aiming for sustainability certifications or ESG reporting compliance.

Tackling ESG Data Gaps in Supplier and Third-Party Reporting

A JAMA Network Open study reveals that patients with private insurance can face monthly costs nearing $600 after a cancer diagnosis, highlighting the disparities based on cancer stage and calling for stronger financial support policies.

High Out-of-Pocket Costs Burden Privately Insured Cancer Patients, Study Finds

Pharma Pulse 7/30/25: Growing Excitement Around Biomarkers in Clinical Trials; Emrelis Could Establish AbbVie as a Competitor in MET-High NSCLC Treatment

In the first part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & distribution services, outlines how the industry's distribution strategy is evolving to ensure timely, safe, and compliant delivery.

News